Modulatory Effects and Molecular Mechanisms of Olive Oil and Other Dietary Lipids in Breast Cancer

Current Pharmaceutical Design

Volumn 17, Issue 8, 2011, Pages 813-830

  Escrich, Eduard ^a   Solanas, Montserrat ^a   Moral, Raquel ^a   Escrich, Raquel ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Breast cancer; Cornoil; Extra virgin olive oil; Mediterranean diet; Minor compounds; Oleic acid; Olive oil; Polyunsaturated fatty acids

Indexed keywords

EXTRA VIRGIN OLIVE OIL; HORMONE; OLIVE OIL; UNCLASSIFIED DRUG;

BREAST CANCER; BREAST CELL; CARCINOGENESIS; CELL FUNCTION; CELL MEMBRANE; CELL STRUCTURE; DIETARY INTAKE; DRUG MECHANISM; GENE EXPRESSION REGULATION; HUMAN; IMMUNE SYSTEM; MEDICAL LITERATURE; MEDITERRANEAN DIET; MODULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CELL MEMBRANE; CELL TRANSFORMATION, NEOPLASTIC; DIETARY FATS, UNSATURATED; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GONADAL STEROID HORMONES; HUMANS; IMMUNE SYSTEM; PLANT OILS; SIGNAL TRANSDUCTION;

EID: 79958199611     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161211795428902     Document Type: Review

References (201)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN2008. Int J Cancer 2010; 127: 2893-917.
2. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention ofcancer: A global perspective. Washington, DC: American Institutefor Cancer Research 2007.
3. Kenemans P, Verstraeten RA, Verheijen RH. Oncogenic pathwaysin hereditary and sporadic breast cancer. Maturitas 2004; 49: 34-43.
4. Ellsworth RE, Decewicz DJ, Shriver CD, Ellsworth DL. Breastcancer in the personal genomics era. Curr Genomics 2010; 11: 146-61.
5. Parkin DM. International variation. Oncogene 2004; 23: 6329-40.
6. Musgrove EA, Sutherland RL. Biological determinants of endocrineresistance in breast cancer. Nat Rev Cancer 2009; 9: 631-43.
7. Martin-Moreno JM, Soerjomataram I, Magnusson G. Cancercauses and prevention: a condensed appraisal in Europe in 2008.Eur J Cancer 2008; 44: 1390-403.
8. Willett WC. In: Schottenfeld D, Fraumeni J, Eds. Cancer epidemiologyand prevention. 3rd ed. New York: Oxford University Press 2006; pp. 405-21.
9. WC. Dietary fat and breast cancer. Toxicol Sci 1999; 52:S127-46.
10. Lee MM, Lin SS. Dietary fat and breast cancer. Annu Rev Nutr 2000; 20: 221-48.
11. Binukumar B, Mathew A. Dietary fat and risk of breast cancer. World J Surg Oncol 2005; 3: 45.
12. Trichopoulou A, Lagiou P, Kuper H, Trichopoulos D. Cancer andMediterranean dietary traditions. Cancer Epidemiol BiomarkersPrev 2000; 9: 869-73.
13. Alarcón de la Lastra C, Barranco MD, Motilva V, Herrerías JM. Mediterranean diet and health: biological importance of olive oil. Curr Pharm Des 2001; 7: 933-50.
14. La Vecchia C. Association between Mediterranean dietary patternsand cancer risk. Nutr Rev 2009; 67: S126-9.
15. Bosetti C, Pelucchi C, La Vecchia C. Diet and cancer in Mediterraneancountries: carbohydrates and fats. Public Health Nutr 2009;12: 1595-600.
16. Ordovas JM, Kaput J, Corella D. Nutrition in the genomics era:cardiovascular disease risk and the Mediterranean diet. Mol NutrFood Res 2007; 51: 1293-9.
17. Martinez-Gonzalez MA, Bes-Rastrollo M, Serra-Majem L, LaironD, Estruch R, Trichopoulou A. Mediterranean food pattern and theprimary prevention of chronic disease: recent developments. NutrRev 2009;67(Suppl 1): S111-6.
18. WC. Diet, nutrition and avoidable cancer. Environ HealthPerspect 1995; 103 (Suppl 8): 165-70.
19. Hashim YZ, Eng M, Gill CI, McGlynn H, Rowland IR. Componentsof olive oil and chemoprevention of colorectal cancer. NutrRev 2005; 63: 374-86.
20. Ramirez-Tortosa MC, Grandaos S, Quiles JL. In: Quiles JL, Ramirez-Tortosa C, Yaqoob P, Eds. Olive oil and health. Oxfordshire:CABI International 2006; pp. 45-62.
21. Owen RW, Giacosa A, Hull WE, et al. Olive-Oil consumption andhealth: the possible role of antioxidants. Lancet Oncol 2000; 1:107-12.
22. Kitts DD. Bioactive substances in food: identification and potentialuses. Can J Physiol Pharmacol 1994; 72: 423-34.
23. Tripoli E, Giammanco M, Tabacchi G, Di Majo D, Giammanco S,La Guardia M. The phenolic compounds of olive oil: structure, biologicalactivity and beneficial effects on human health. Nutr ResRev 2005; 18: 98-112.
24. Karantonis HC, Tsantila N, Stamatakis G, et al. Bioactive polarlipids in olive oil, pomace and waste by products. J Food Biochem 2008; 32: 443-59.
25. Tsoupras AB, Iatrou C, Frangia C, Demopoulos CA. The implicationof Platelet Activating Factor in cancer growth and metastasis:potent beneficial role of PAF-inhibitors and antioxidants. InfectDisord Drug Targets 2009; 9: 390-9.
26. Pérez-Jiménez F, Ruano J, Perez-Martinez P, Lopez-Segura F, Lopez-Miranda J. The influence of olive oil on human health: not aquestion of fat alone. Mol Nutr Food Res 2007; 51: 1199-208.
27. Visioli F, Galli C. Biological properties of olive oil phytochemicals. Crit Rev Food Sci Nutr 2002; 42: 209-21.
28. Owen RW, Haubner R, Wurtele G, et al. Olives and olive oil incancer prevention. Eur J Cancer Prev 2004; 13: 319-26.
29. Bougnoux P, Giraudeau B, Couet C. Diet, cancer, and the lipidome. Cancer Epidemiol Biomarkers Prev 2006; 15: 416-21.
30. Kushi L, Giovannucci E. Dietary fat and cancer. Am J Med 2002;113: 63S-70S.
31. Hunter DJ, Spiegelman D, Adami HO, et al. Cohort studies of fatintake and the risk of breast cancer - a pooled analysis. N Engl JMed 1996; 334: 356-61.
32. Hunter D J. Role of dietary fat in the causation of breast cancer:counterpoint. Cancer Epidemiol Biomarkers Prev 1999; 8: 9-13.
33. Schulz M, Hoffmann K, Weikert C, et al. Identification of a dietarypattern characterized by high-fat food choices associated with increasedrisk of breast cancer: the European Prospective Investigationinto Cancer and Nutrition (EPIC)-Potsdam Study. Br J Nutr 2008; 100: 942-6.
34. Willett WC. Dietary fat intake and cancer risk: a controversial andinstructive story. Semin Cancer Biol 1998; 8: 245-53.
35. Bingham SA, Luben R, Welch A, Wareham N, Khaw KT, Day N.Are imprecise methods obscuring a relation between fat and breastcancer? Lancet 2003; 362: 212-4.
36. Prentice RL, Caan B, Chlebowski RT, et al. Low-fat dietary patternand risk of invasive breast cancer: the Women's Health InitiativeRandomized Controlled Dietary Modification Trial. JAMA 2006;295: 629-42.
37. Mayne ST. Women's Health Initiative: complex answers to simplequestions on dietary fat and breast cancer. Nat Clin Pract Oncol 2006; 3: 285.
38. Fay MP, Freedman LS, Clifford CK, Midthune DN. Effect ofdifferent types and amounts of fat on the development of mammarytumors in rodents: a review. Cancer Res 1997; 57: 3979-88.
39. Bartsch H, Nair J, Owen RW, Bartsch H. Dietary polyunsaturatedfatty acids and cancers of the breast and colorectum: emerging evidencefor their role as risk modifiers. Carcinogenesis 1999; 20:2209-18.
40. Hilakivi-Clarke L. Nutritional modulation of terminal end buds: itsrelevance to breast cancer prevention. Curr Cancer Drug Targets 2007; 7: 465-74.
41. MacLennan M, Ma DWL. Role of dietary fatty acids in mammarygland development and breast cancer. Breast Cancer Res 2010; 12:211.
42. Ip C. Review of the effects of trans fatty acids, oleic acid, n-3polyunsaturated fatty acid, and conjugated linoleic acid on mammarycarcinogenesis in animals. Am J Clin Nutr 1997; 66: 1523S-9S.
43. Escrich E, Solanas M, Moral R. In: Quiles JL, Ramirez-Tortosa C, Yaqoob P, Eds. Olive oil and health. Oxfordshire: CABI International 2006; pp. 317-74.
44. Soto-Guzman A, Navarro-Tito N, Castro-Sanchez L, Martinez-Orozco R, Salazar EP. Oleic acid promotes MMP-9 secretion andinvasion in breast cancer cells. Clin Exp Metastasis 2010; 27: 505-15.
45. Hanf V, Gonder U. Nutrition and primary prevention of breastcancer: foods, nutrients and breast cancer risk. Eur J Obstet GynecolReprod Biol 2005; 123: 139-49.
46. Cicerale S, Conlan XA, Sinclair AJ, Keast RS. Chemistry andhealth of olive oil phenolics. Crit Rev Food Sci Nutr 2009; 49: 218-36.
47. Cohen LA, Epstein M, Pittman B, Rivenson A. The influence ofdifferent varieties of olive oil on N-methylnitrosourea (NMU)-induced mammary tumorigenesis. Anticancer Res 2000; 20: 2307-12.
48. Owen RW, Giacosa A, Hull WE. Olive-oil consumption andhealth: the possible role of antioxidants. Lancet Oncol 2000; 1:107-12.
49. Solanas M, Moral R, Escrich E. Effects of dietary (n-6) polyunsaturatedlipids on experimental mammary carcinogenesis. J Women'sCancer 2000; 2: 67-72.
50. Escrich E, Solanas M, Soler M, et al. Dietary polyunsaturated n-6lipids effects on the growth and fatty acid composition of ratmammary tumors. J Nutr Biochem 2001; 12: 536-49.
51. Solanas M, Moral R, Escrich E. The stimulating effect of a high-fatn-6 polyunsaturated diet on rat DMBA-induced mammary tumorsis not related to changes in c-Ha-ras1 mRNA tumor expression. Nutr Res 2001; 21: 1261-73.
52. Solanas M, Hurtado A, Costa I, et al. Effects of a high olive oil dieton the clinical behavior and histopathological features of ratDMBA-induced mammary tumors compared with a high corn oildiet. Int J Oncol 2002; 21: 745-53.
53. Moral R, Solanas M, García G, Colomer R and Escrich E: Modulationof EGFR and neu expression by n-6 and n-9 high-fat diets inexperimental mammary adenocarcinomas. Oncol Rep 2003; 10:1417-24.
54. Moral R, Escrich R, Solanas M. Diets high in corn oil or extravirginolive oil provided from weaning advance sexual maturationand differentially modify susceptibility to mammary carcinogenesisin female rats. Nutr Cancer 2011 Mar 4:1. [Epub ahead of print].
55. Guthrie N, Carroll KK. Specific versus non-specific effects ofdietary fat on carcinogenesis. Prog Lipid Res 1999; 38: 261-71.
56. González-Santiago M, Fonollá J, Lopez-Huertas E. Human absorptionof a supplement containing purified hydroxytyrosol, a naturalantioxidant from olive oil, and evidence for its transient associationwith low-density lipoproteins. Pharmacol Res 2010; 61: 364-70.
57. Carroll KK, Khor HT. Effect of level and type of dietary fat onincidence of mammary tumors induced in female Sprague-Dawleyrats by 7,12-dimethylbenz(·)anthracene. Lipids 1971; 6: 415-20.
58. Cohen LA, Thompson DO, Maeura Y, et al. Dietary fat and mammarycancer. I. Promoting effects of different dietary fats on NNitrosomethylurea-induced rat mammary tumorigenesis. J NatlCancer Inst 1986; 77: 33-42.
59. Wynder EL, Cohen LA, Muscat JE, et al: Breast cancer: weighingthe evidence for a promoting role of dietary fat. J Natl Cancer Inst 1997; 89: 766-75.
60. Russo IH, Russo J. Mammary gland neoplasia in long-term rodentstudies. Environ Health Perspect 1996; 104: 938-67.
61. Hilakivi-Clarke L, Clarke R, Onojafe I, et al. A maternal diet highin n-6 polyunsaturated fats alters mammary gland development,puberty onset, and breast cancer risk among female rat offspring. Proc Natl Acad Sci USA 1997; 94: 9372-77.
62. Snyderwine EG, Davis CD, Schut HA, Roberts-Thomson SJ. Proliferation, development and DNA adduct levels in the mammarygland of rats given 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and a high fat diet. Carcinogenesis 1998; 19: 1209-15.
63. Costa I, Solanas M, Escrich E. Histopathologic characterization ofmammary neoplastic lesions induced with 7,12 dimethylbenz(alpha)anthracene in the rat: a comparative analysis with humanbreast tumors. Arch Pathol Lab Med 2002; 126: 915-27.
64. Costa I, Moral R, Solanas M, et al. High-fat corn oil diet promotesthe development of high histologic grade rat DMBA-inducedmammary adenocarcinomas, while high olive oil diet does not. Breast Cancer Res Treat 2004; 86: 225-35.
65. Costa I, Moral R, Solanas M, Andreu FJ, Ruiz de Villa MC, Escrich E. High corn oil and extra virgin olive oil diets and experimentalmammary carcinogenesis: clinicopathological and immunohistochemicalp21Ha-Ras expression study. Virchows Archiv 2011; 458: 141-51.
66. Pitot H. The molecular biology of carcinogenesis. Cancer 1993;72(Suppl): 962-70.
67. Kritchevski D, Weber MM, Klurfeld DM. Dietary fat versus caloriccontent in initiation and promotion of 7,12-dimethylbenz(a)anthracene-induced mammary tumorigenesis. CancerRes 1984; 44: 3174-7.
68. Kinnunen PK, Koiv A, Lehtonen JY, Rytömaa M, Mustonen P.Lipid dynamics and peripheral interactions of proteins with membranesurfaces. Chem Phys Lipids 1994; 73: 181-207.
69. Albi E, Viola Magni MP. The role of intranuclear lipids. Biol Cell 2004; 96: 657-67.
70. Stavric B. Role of chemopreventers in human diet. Clin Biochem 1994; 27: 319-32.
71. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functionsand human disease. Int J Biochem Cell Biol. 2007; 39: 44-84.
72. Ferguson LR, Philpott M. Nutrition and mutagenesis. Annu RevNutr 2008; 28: 313-29.
73. Gago-Dominguez M, Jiang X, Castelao JE. Lipid peroxidation,oxidative stress genes and dietary factors in breast cancer protection:a hypothesis. Breast Cancer Res 2007; 9: 201.
74. Rose DP. Effects of dietary fatty acids on breast and prostatecancers: evidence from in vitro experiments and animal studies. Am J Clin Nutr 1997; 66: 1513S-22S.
75. Stoll BA. N-3 fatty acids and lipid peroxidation in breast cancerinhibition. Br J Nutr 2002; 87: 193-8.
76. Larsson S, Kumlin M, Ingelman-Sundberg M, Wolk A. Dietarylong-chain n-3 fatty acids for the prevention of cancer: a review ofpotential mechanisms. Am J Clin Nutr 2004; 79: 935-45.
77. Sun SY, Hail N Jr, Lotan R. Apoptosis as a novel target for cancerchemoprevention. J Natl Cancer Inst 2004; 96: 662-72.
78. Solanas M, Grau L, Moral R, et al. Dietary olive oil and corn oildifferentially affect experimental breast cancer through distinctmodulation of the p21ras signaling and the proliferation-apoptosisbalance. Carcinogenesis 2010; 31: 871-9.
79. Galli C, Visioli F. Antioxidant and other activities of phenolics inolives/olive oil, typical components of the Mediterranean diet. Lipids 1999; 34: S23-6.
80. Hashim YZ, Eng M, Gill C I, McGlynn H, Rowland I. R. Componentsof olive oil and chemoprevention of colorectal cancer. NutrRev 2005; 63: 374-86.
81. Gill CI, Boyd A, McDermott E, et al. Potential anti-cancer effectsof virgin olive oil phenols on colorectal carcinogenesis models invitro. Int J Cancer 2005; 117: 1-7.
82. Della Ragione F, Cucciolla V, Borriello A, et al. Pyrrolidinedithiocarbamate induces apoptosis by a cytochrome c-dependentmechanism. Biochem Biophys Res Commun 2000; 268: 942-6.
83. Fabiani R, De Bartolomeo A, Rosignoli P, Servili M, Montedoro GF, Morozzi G. Cancer chemoprevention by hydroxytyrosol isolatedfrom virgin olive oil through G1 cell cycle arrest and apoptosis. Eur J Cancer Prev 2002; 11: 351-8.
84. Zhang X, Cao J, Jiang L, Zhong L. Suppressive effects of hydroxytyrosolon oxidative stress and nuclear Factor-kappaB activationin THP-1 cells. Biol Pharm Bull 2009; 32: 578-82.
85. Davis DL, Bradlow HL, Wolff M, Woodruff T, Hoel DG, Anton-Culver H. Medical hypothesis: xenoestrogens as preventable causesof breast cancer. Environ Health Perspect 1993; 101: 372-7.
86. Dickson RB, Thompson EW, Lippman ME. Regulation of proliferation,invasion and growth factor synthesis in breast cancer bysteroids. J Steroid Biochem Mol Biol 1990; 37: 305-16.
87. Gadducci A, Biglia N, Sismondi P, Genazzani AR. Breast cancerand sex steroids: critical review of epidemiological, experimentaland clinical investigations on etiopathogenesis, chemopreventionand endocrine treatment of breast cancer. Gynecol Endocrinol 2005; 20: 343-60.
88. Key TJ, Appleby PN, Reeves GK, et al. Body mass index, serumsex hormones, and breast cancer risk in postmenopausal women. JNatl Cancer Inst 2003; 95: 1218-26.
89. Lahmann PH, Hoffmann K, Allen N, et al. Body size and breastcancer risk: findings from the European Prospective Investigationinto Cancer And Nutrition (EPIC). Int J Cancer 2004; 111: 762-71.
90. Deslypere JP, Verdonck L, Vermeulen A. Fat tissue: a steroidreservoir and site of steroid metabolism. J Clin Endocrinol Metab 1985; 61: 564-70.
91. Miller WR. Aromatase and the breast: regulation and clinicalaspects. Maturitas 2006; 54: 335-41.
92. Martin ME, Vranckxm R, Benassayag C, Nunez EA. Modificationsof the properties of human sex steroid-binding protein by nonesterifiedfatty acids. J Biol Chem 1986; 261: 2954-9.
93. Jobling S, Reynolds T, White R, Parker MG, Sumpter JP. A varietyof environmentally persistent chemicals, including some phthalateplasticizers, are weakly estrogenic. Environ Health Perspect 1995;103: 582-7.
94. Sonnenschein C, Soto AM. An updated review of environmentalestrogen and androgen mimics and antagonists. J Steroid BiochemMol Biol 1998; 65: 143-50.
95. Fernandez SV, Russo J. Estrogen and xenoestrogens in breastcancer. Toxicol Pathol 2010; 38: 110-22.
96. Hu X, Juneja SC, Maihle NJ, Cleary MP. Leptin - a growth factorin normal and malignant breast cells and for normal mammarygland development. J Natl Cancer Inst 2002; 94: 1704-11.
97. Cleary MP, Grossmann ME. Obesity and breast cancer: the estrogenconnection. Endocrinology 2009; 150: 2537-42.
98. Grossmann ME, Ray A, Nkhata KJ, et al. Obesity and breastcancer: status of leptin and adiponectin in pathological processes. Cancer Metastasis Rev 2010; 29: 641-53.
99. Ray A, Nkhata KJ, Cleary MP. Effects of leptin on human breastcancer cell lines in relationship to estrogen receptor and HER2status. Int J Oncol 2007; 30: 1499-509.
100. Reyes N, Reyes I, Tiwari R, Geliebter J. Effect of linoleic acid onproliferation and gene expression in the breast cancer cell lineT47D. Cancer Lett 2004; 209: 25-35.
101. Hilakivi-Clarke L, Stoica A, Raygada M, Martin MB. Consumptionof a high-fat diet alters estrogen receptor content, protein kinase Cactivity, and mammary gland morphology in virgin and pregnantmice and female offspring. Cancer Res 1998; 58: 654-60.
102. Cohen LA. Mechanisms by which dietary fat may stimulate mammarycarcinogenesis in experimental animals. Cancer Res 1981;41: 3808-10.
103. Sylvester PW, Russell M, Ip M, Ip C. Comparative effects ofdifferent animal and vegetable fats fed before and during carcinogenadministration on mammary tumorigenesis, sexual maturation,and endocrine function in rats. Cancer Res 1986; 46: 757-62.
104. Lomeo F, Khokher MA, Dandona P. Unsaturated fatty acids potentiateinsulin action on adypocites. Prog Lipid Res 1986; 25: 511-3.
105. Buckland G, Bach A, Serra-Majem L. Obesity and the Mediterraneandiet: a systematic review of observational and interventionstudies. Obes Rev 2008; 9: 582-93.
106. Spector AA, Burns CP. Biological and therapeutic potential ofmembrane lipid modification in tumors. Cancer Res 1987; 47:4529-37.
107. Clandinin MT, Cheema S, Field CJ, et al. Dietary fat: exogenousdetermination of membrane structure and cell function. FASEB J 1991; 5: 2761-8.
108. Cave WT Jr. Omega-3 polyunsaturated fatty acids in rodent modelsof breast cancer. Breast Cancer Res Treat 1997; 46: 239-46.
109. Hulbert AJ, Turner N, Storlien LH, Else PL. Dietary fats andmembrane function: implications for metabolism and disease. BiolRev Camb Philos Soc 2005; 80: 155-69.
110. Welsch C. Enhancement of mammary tumorigenesis by dietary fat:review of potential mechanisms. Am J Clin Nutr 1987; 45: 192-202.
111. Dowhan W, Mileykovskaya E, Bogdanov M. Diversity and versatilityof lipid-protein interactions revealed by molecular genetic approaches. Biochim Biophys Acta 2004; 1666: 19-39.
112. Escribá PV, Ozaita A, Ribas C, et al. Role of lipid polymorphismin G protein-membrane interactions: nonlamellar-prone phospholipidsand peripheral protein binding to membranes. Proc Natl Acad Sci USA 1997; 94: 11375-80.
113. Yang Q, Alemany R, Casas J, et al. Influence of the membranelipid structure on signal processing via G protein-coupled receptors. Mol Pharmacol 2005; 68: 210-7.
114. Simons K, Ikonen E. Functional rafts in cell membranes. Nature 1997; 387: 569-72.
115. Biondo PD, Brindley DN, Sawyer MB, Field CJ. The potential fortreatment with dietary long-chain polyunsaturated n-3 fatty acidsduring chemotherapy. J Nutr Biochem 2008; 19: 787-96.
116. Chapkin RS, Seo J, McMurray DN, Lupton JR. Mechanisms bywhich docosahexaenoic acid and related fatty acids reduce coloncancer risk and inflammatory disorders of the intestine. Chem PhysLipids 2008; 153: 14-23.
117. Ma DW, Seo J, Davidson LA, et al. n-3 PUFA alter caveolae lipidcomposition and resident protein localization in mouse colon. FASEB J 2004; 18: 1040-2.
118. Li Q, Zhang Q, Wang M, et al. Eicosapentaenoic acid modifieslipid composition in caveolae and induces translocation of endothelialnitric oxide synthase. Biochimie 2007; 89: 169-77.
119. Li Q, Zhang Q, Wang M, et al. Docosahexaenoic acid affectsendothelial nitric oxide synthase in caveolae. Arch Biochem Biophys 2007; 466: 250-9.
120. Altenburg and Siddiqui 2009 Altenburg JD, Siddiqui RA. Omega-3polyunsaturated fatty acids down-modulate CXCR4 expression andfunction in MDA-MB-231 breast cancer cells. Mol Cancer Res 2009; 7: 1013-20.
121. Sekimizu K. Interactions between DNA replication-related proteinsand phospholipid vesicles in vitro. Chem. Phys. Lipids 1994; 73:223-30.
122. Tomassoni ML, Amori D, Magni MV. Changes of nuclear membranelipid composition affect RNA nucleocytoplasmic transport. Biochem Biophys Res Commun 1999; 258: 476-81.
123. Jiang WG, Bryce RP, Horrobin DF. Essential fatty acids: molecularand cellular basis of their anti-cancer action and clinical implications. Crit Rev Oncol Hematol 1998; 27: 179-209.
124. Holder JW, Elmore E, Barret JC. Gap junction function and cancer. Cancer Res 1993; 53: 3475-85.
125. Jiang WG, Bryce RP, Mansel RE. Gamma linolenic acid regulatesgap junction communication in endothelial cells and their interactionwith tumour cells. Prostaglandins Leukot Essent Fatty Acids 1997; 56: 307-16.
126. Sumida C, Graber R, Nunez E. Role of fatty acids in signal transduction:modulators and messengers. Prostaglandins Leukot EssentFatty Acids 1993; 48: 117-22.
127. Jump DB. Fatty acid regulation of gene transcription. Crit Rev ClinLab Sci 2004; 41: 41-78.
128. Banni S, Angioni E, Casu V, et al. Decrease in linoleic acid metabolitesas a potential mechanism in cancer risk reduction by conjugatedlinoleic acid. Carcinogenesis 1999; 20: 1019-24.
129. Bartoli R, Fernandez-Bañares F, Navarro E, et al. Effect of oliveoil on early and late events of colon carcinogenesis in rats: modulationof arachidonic acid metabolism and local prostaglandin E(2)synthesis. Gut 2000; 46: 191-9.
130. Yamaki T, Yano T, Satoh H, et al. High oleic acid oil suppresseslung tumorigenesis in mice through the modulation of extracellularsignal-regulated kinase cascade. Lipids 2002; 37: 783-8.
131. Nomikos T, Fragopoulou E, Antonopoulou S. Food ingredients andlipid mediators. Curr NutrFood Sci 2007; 3: 255-76.
132. Demopoulos CA, Karantonis HC, Antonopoulou S. Platelet activatingfactor- a molecular link between atherosclerosis theories. Eur JLipid Sci Technol 2003; 150: 705-16.
133. Nishizuka Y. Protein Kinase C and lipid signaling for sustainedcellular responses. FASEB J 1995; 9: 484-96.
134. Palmantier R, George MD, Akiyama SK, et al. Cis-polyunsaturatedfatty acids stimulate beta1 integrin-mediated adhesion of humanbreast carcinoma cells to type IV collagen by activating proteinkinases C-epsilon and -mu. Cancer Res 2001; 61: 2445-52.
135. Murray NR, Weems C, Chen LA, et al. Protein kinase C betaII andTGFbetaRII in omega-3 fatty acidmediated inhibition of colon carcinogenesis.J Cell Biol 2002; 157: 915-20.
136. Vacaresse N, Lajoie-Mazenc I, Auge N, et al. Activation of epithelialgrowth factor receptor pathway by unsaturated fatty acids. CircRes 1999; 85: 892-9.
137. Schley PD, Brindley DN, Field CJ. (n-3) PUFA alter raft lipidcomposition and decrease epidermal growth factor receptor levelsin lipid rafts of human breast cancer cells. J Nutr 2007; 137: 548-53.
138. Menendez JA, Vellon L, Colomer R, Lupu R. Oleic acid, the mainmonounsaturated fatty acid of olive oil, suppresses Her-2/neu(erbB-2) expression and synergistically enhances the growth inhibitoryeffects of trastuzumab (HerceptinTM) in breast cancer cellswith Her-2/neu oncogene amplification. Ann Oncol 2005; 16: 359-71.
139. Hardy S, St-Onge GG, Joly E, Langelier Y, Prentki M. Oleatepromotes the proliferation of breast cancer cells via the G proteincoupledreceptor GPR40. J Biol Chem 2005; 280: 13285-91.
140. Karnoub AE, Weinberg RA. Ras oncogenes: split personalities. NatRev Mol Cell Biol 2008; 9: 517-31.
141. Singh J, Hamid R, Reddy BS. Dietary fat and colon cancer: modulationof cyclooxygenase-2 by types and amount of dietary fat duringthe postinitiation stage of colon carcinogenesis. Cancer Res 1997; 57: 3465-70.
142. Singh J, Hamid R, Reddy BS. Dietary fat and colon cancer: modulatingeffect of types and amount of dietary fat on ras-p21 functionduring promotion and progression stages of colon cancer. CancerRes 1997; 57: 253-8.
143. Davidson LA, Lupton JR, Jiang Y, Chapkin RS. Carcinogen anddietary lipid regulate ras expression and localization in rat colonwithout affecting farnesylation kinetics. Carcinogenesis 1999; 20:785-91.
144. Rao CV, Newmark HL, Reddy BS. Chemopreventive effect ofsqualene on colon cancer. Carcinogenesis 1998; 19: 287-90.
145. Karin M, Lin A. NF-kappaB at the crossroads of life and death. NatImmunol 2002; 3: 221-7.
146. Bharti AC, Aggarwal BB. Nuclear factor-kappa B and cancer: itsrole in prevention and therapy. Biochem Pharmacol 2002; 64: 883-8.
147. Tiwari RK, Mukhopadhyay B, Telang NT, Osborne MP. Modulationof gene expression by selected fatty acids in human breast cancercells. Anticancer Res 1991; 11: 1383-8.
148. Fernandes G, Venkatraman JT. Modulation of breast cancer growthin nude mice by omega 3 lipids. World Rev Nutr Diet 1991; 66:488-503.
149. Solanas M, Escrich E, Rouzaut A, et al. Deregulated expression ofthe PCPH proto-oncogene in rat mammary tumors induced with7,12-dimethylbenz[a]anthracene. Mol Carcinog 2002; 33: 219-27.
150. Moral R, Solanas M, Garcia G, et al. High corn oil and high extravirgin olive oil diets have different effects on the expression of differentiation-related genes in experimental mammary tumors. OncolRep 2008; 20: 429-35.
151. Hamid R, Sing J, Reddy BS, Cohen LA. Inhibition by dietarymenhaden oil of cyclooxygenase-1 and -2 in N-nitrosomethylureainducedrat mammary tumor. Int J Oncol 1999; 14: 523-8.
152. Rao CV, Hirose Y, Indranie C, Reddy BS. Modulation of experimentalcolon tumorigenesis by types and amounts of dietary fattyacids. Cancer Res 2001; 61: 1927-33.
153. Narayanan BA, Narayanan NK, Simi B, Reddy BS. Modulation ofinducible nitric oxide synthase and related proinflammatory genesby the omega-3 fatty acid docosahexaenoic acid in human coloncancer cells. Cancer Res 2003; 63: 972-9.
154. Davidson LA, Nguyen DV, Hokanson RM, et al. Chemopreventiven-3 polyunsaturated fatty acids reprogram genetic signatures duringcolon cancer initiation and progression in the rat. Cancer Res 2004;64: 6797-804.
155. Jurek D, Udilova N, Jozkowicz A, et al. Dietary lipid hydroperoxidesinduce expression of vascular endothelial growth factor(VEGF) in human colorectal tumor cells. FASEB J 2005; 19: 97-9.
156. Davis CD, Snyderwine EG. Analysis of EGFR, TGFalpha, neu andc-myc in 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridineinducedmammary tumors using RTPCR. Carcinogenesis 1995; 16:3087-92.
157. Hughes-Fulford M, Chen Y. Tjandrawinata RR. Fatty acid regulatesgene expression and growth of human prostate cancer PC-3cells. Carcinogenesis 2001; 22: 701-7.
158. Tillotson JK, Darzynkiewicz Z, Cohen LA, Ronai Z. Effects oflinoleic acid on mammary tumor cell proliferation are associatedwith changes in p53 protein expression. Int J Oncol 1993; 3: 81-7.
159. Wu B, Iwakiri R, Ootani A, et al. Dietary corn oil promotes coloncancer by inhibiting mitochondriadependent apoptosis inazoxymethane-treated rats. Exp Biol Med 2004; 229: 1017-25.
160. Kachhap SK, Dange P, Ghosh SN. Effect of omega-6 polyunsaturatedfatty acid (linoleic acid) on BRCA1 gene expression in MCF-7 cell line. Cancer Lett 2000; 154: 115-20.
161. Bernard-Gallon DJ, Vissac-Sabatier C, Antoine-Vincent D, et al. Differential effects of n-3 and n-6 polyunsaturated fatty acids onBRCA1 and BRCA2 gene expression in breast cell lines. Br J Nutr 2002; 87: 281-9.
162. Dimri M, Bommi PV, Sahasrabuddhe AA, Khandekar JD, DimriGP. Dietary omega-3 polyunsaturated fatty acids suppress expressionof EZH2 in breast cancer cells. Carcinogenesis 2010; 31: 489-95.
163. Jiang WG, Hiscox S, Hallett MB, et al. Regulation of the expressionof E-cadherin on human cancer cells by gamma-linolenic acid(GLA). Cancer Res 1995; 55: 5043-8.
164. Jiang WG, Hiscox S, Horrobin DF, Bryce RP, Mansel RE. Gammalinolenic acid regulates expression of maspin and the motility ofcancer cells. Biochem Biophys Res Commun 1997; 237: 639-44.
165. Spencer L, Mann C, Metcalfe M, et al. The effect of omega-3 FAson tumour angiogenesis and their therapeutic potential. Eur J Cancer 2009; 45: 2077-86.
166. Moral R, Solanas M, Manzanares EM, et al. Influence of DMBAinducedmammary cancer on the liver CPT I, mit HMG-CoA synthaseand PPARα mRNA expression in rats fed low or high corn oildiet. Int J Mol Med 2004; 14: 283-7.
167. Escrich E, Moral R, García G, et al. Identification of novel differentiallyexpressed genes by the effect of a high-fat n-6 diet in experimentalbreast cancer. Mol Carcinog 2004; 40: 73-8.
168. Reyes N, Reyes I, Tiwari R, Geliebter J. Effect of linoleic acid onproliferation and gene expression in the breast cancer cell lineT47D. Cancer Lett 2004; 209: 25-35.
169. Hammamieh R, Chakraborty N, Miller SA, et al. Differentialeffects of omega-3 and omega-6 Fatty acids on gene expression inbreast cancer cells. Breast Cancer Res Treat 2007; 101: 7-16.
170. Alquobaili F, Miller SA, Muhie S, Day A, Jett M, Hammamieh R.Estrogen receptor-dependent genomic expression profiles in breastcancer cells in response to fatty acids. J Carcinog 2010; 4: 8-17.
171. Medvedovic M, Gear R, Freudenberg JM, et al. Influence of fattyacid diets on gene expression in rat mammary epithelial cells. Physiol Genomics 2009; 38: 80-8.
172. Reyes N, Iatropoulos M, Mittelman A, Geliebter J. Microarrayanalysis of diet-induced alterations in gene expression in the ACIrat prostate. Eur J Cancer Prev 2002; 11: S37-S2.
173. Hughes-Fulford M, Li CF, Boonyaratanakornkit J, Sayyah S.Arachidonic acid activates phosphatidylinositol 3-kinase signalingand induces gene expression in prostate cancer. Cancer Res 2006;66: 1427-33.
174. Davidson LA, Wang N, Shah MS, Lupton JR, Ivanov I, Chapkin RS. n-3 Polyunsaturated fatty acids modulate carcinogen-directednon-coding microRNA signatures in rat colon. Carcinogenesis 2009; 30: 2077-84.
175. Balkwill F, Mantovani A. Inflammation and cancer: back toVirchow? Lancet 2001; 357: 539-45.
176. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420: 860-7.
177. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-relatedinflammation. Nature 2008; 454: 436-44.
178. Grivennikov SI, Karin M. Dangerous liaisons: STAT3 and NFkappaBcollaboration and crosstalk in cancer. Cytokine GrowthFactor Rev 2010; 21: 11-9.
179. de Visser KE, Eichten A, Coussens LM. Paradoxical roles of theimmune system during cancer development. Nat Rev Cancer 2006;6: 24-37.
180. Philpott M, Ferguson LR. Immunonutrition and cancer. Mutat Res 2004; 551: 29-42.
181. Yaqoob P. In: Quiles JL, Ramirez-Tortosa C, Yaqoob P, Eds. Oliveoil and health. Oxfordshire: CABI International 2006; pp. 265-83.
182. Utermohlen V, Tucker MAM. Possible effects of dietary n-6 seriespolyunsaturated fatty acids on the development of immune dysfunctionand infection. Proc Nutr Soc 1986; 45: 327-31.
183. Calder PC. Dietary fatty acids and the immune system. Lipids 1999; 34: S137-40.
184. Hwang D. Fatty acids and immune responses - a new perspective insearching for clues to mechanism. Annu Rev Nutr 2000; 20: 431-56.
185. Stulnig TM. Immunomodulation by polyunsaturated fatty acids:mechanisms and effects. Int Arch Allergy Immunol 2003; 132:310-21.
186. Calder PC, Yaqoob P, Thies F, Wallace FA, Miles EA. Fatty acidsand lymphocyte functions. Brit J Nutr 2002; 87: S31-8.
187. Kelley DS. Modulation of human immune and inflammatoryresponses by dietary fatty acids. Nutrition 2001; 17: 669-73.
188. Yaqoob P, Calder PC. Fatty acids and immune function: newinsights into mechanisms. Br J Nutr 2007; 98(Suppl 1): S41-5.
189. Kossoy G, Madar Z, Ben-Hur H, et al. Transplacental effect of a15% olive-oil diet on functional activity of immune components inthe spleen and colon tumors of rat offspring. Oncol Rep 2001; 8:1045-9.
190. Yaqoob P. In: Quiles JL, Ramirez-Tortosa C, Yaqoob P, Eds. Oliveoil and health. Oxfordshire: CABI International 2006; pp. 265-83.
191. Sánchez-Fidalgo S, Villegas I, Cárdeno A, et al. Extra-virgin oliveoil-enriched diet modulates DSS-colitis-associated colon carcinogenesisin mice. Clin Nutr 2010; 29: 663-73.
192. Miles EA, Zoubouli P, Calder PC. Differential anti-inflammatoryeffects of phenolic compounds from extra virgin olive oil identifiedin human whole blood cultures. Nutrition 2005; 21: 389-94.
193. Beauchamp GK, Keast RS, Morel D, et al. Phytochemistry: ibuprofen-like activity in extra-virgin olive oil. Nature 2005; 437: 45-6.
194. Harikumar KB, Sung B, Tharakan ST, et al. Sesamin manifestschemopreventive effects through the suppression of NF-kappa Bregulatedcell survival, proliferation, invasion, and angiogenic geneproducts. Mol Cancer Res 2010; 8: 751-61.
195. Bellido C, López-Miranda J, Blanco-Colio LM, et al. Butter andwalnuts, but not olive oil, elicit postprandial activation of nucleartranscription factor kappaB in peripheral blood mononuclear cellsfrom healthy men. Am J Clin Nutr 2004; 80: 1487-91.
196. Perez-Martinez P, Lopez-Miranda J, Blanco-Colio L, et al. Thechronic intake of a Mediterranean diet enriched in virgin olive oil,decreases nuclear transcription factor kappaB activation in peripheralblood mononuclear cells from healthy men. Atherosclerosis 2007; 194: e141-6.
197. Brunelleschi S, Bardelli C, Amoruso A, et al. Minor polar compoundsextra-virgin olive oil extract (MPC-OOE) inhibits NFkappaB translocation in human monocyte/macrophages. PharmacolRes 2007; 56: 542-9.
198. Perez-Jimenez F, Alvarez de Cienfuegos G, Badimon L, et al. International conference on the healthy effect of virgin olive oil. Eur J Clin Invest 2005; 35: 421-4.
199. López-Miranda J, Pérez-Jiménez F, Ros E, et al. Olive oil andhealth: summary of the II international conference on olive oil andhealth consensus report, Jaén and Córdoba (Spain) 2008. Nutr MetabCardiovasc Dis 2010; 20: 284-94.
200. Cottet V, Touvier M, Fournier A, et al. Postmenopausal breastcancer risk and dietary patterns in the E3N-EPIC prospective cohortstudy. Am J Epidemiol 2009; 170: 1257-67.
201. Trichopoulou A, Bamia C, Lagiou P, et al. Conformity to traditionalMediterranean diet and breast cancer risk in the Greek EPIC(European Prospective Investigation into Cancer and Nutrition) cohort. Am J Clin Nutr 2010; 92: 620-5.